Hsbc Holdings PLC raised its stake in Xylem Inc. (NYSE:XYL – Free Report) by 23.5% during the 1st quarter, HoldingsChannel reports. The firm owned 2,471,257 shares of the industrial products company’s stock after acquiring an additional 470,566 shares during the quarter. Hsbc Holdings PLC’s holdings in Xylem were worth $295,249,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Wexford Capital LP purchased a new position in Xylem in the 3rd quarter worth approximately $27,000. Commonwealth Retirement Investments LLC purchased a new stake in Xylem during the 4th quarter worth $27,000. Board of the Pension Protection Fund acquired a new position in Xylem in the 4th quarter worth $27,000. Entrust Financial LLC acquired a new stake in shares of Xylem during the fourth quarter valued at about $45,000. Finally, FWL Investment Management LLC purchased a new stake in shares of Xylem during the second quarter worth about $43,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Stock Down 1.9%
NYSE:XYL opened at $122.96 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The company has a market capitalization of $29.23 billion, a price-to-earnings ratio of 30.59, a price-to-earnings-growth ratio of 1.75 and a beta of 1.03. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The stock has a 50-day simple moving average of $113.23 and a 200 day simple moving average of $123.48.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a dividend of $0.43 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.4%. Xylem’s dividend payout ratio (DPR) is 42.79%.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on XYL. Stifel Nicolaus lowered their price objective on Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Citigroup cut their target price on Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Barclays reduced their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. UBS Group lifted their price target on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Finally, JPMorgan Chase & Co. cut their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $153.31.
Check Out Our Latest Stock Analysis on Xylem
Insiders Place Their Bets
In other Xylem news, Director Jerome A. Peribere bought 1,210 shares of the stock in a transaction on Monday, May 4th. The stock was purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.32% of the company’s stock.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Read More
- Five stocks we like better than Xylem
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
